• In late May 2026, PrognoCIS announced the launch of PrognoPay, an embedded payment solution within its EHR platform powered by Global Payments, allowing healthcare practices to process patient payments directly inside clinical workflows.
• This move highlights Global Payments’ deeper push into embedded healthcare payments, integrating enterprise-grade processing into everyday provider and patient interactions alongside its larger Worldpay integration efforts.
• We’ll now examine how this deeper EHR-embedded presence in healthcare could influence Global Payments’ existing investment narrative and long-term positioning.

This technology could replace computers: discover 29 stocks that are working to make quantum computing a reality.

Global Payments Investment Narrative Recap

To own Global Payments, you need to believe its scale in merchant acquiring, software, and Worldpay integration can offset integration hiccups, competition, and margin pressure. The PrognoPay launch fits the long term push into embedded payments, but it does not materially change the near term focus on executing the Worldpay integration or the key risk around integration missteps and one off items already affecting reported results.

The recent announcement that CKE Restaurants will roll out the Genius POS platform across more than 2,400 U.S. locations is more central to the current catalyst story, because it showcases how Global Payments aims to extend integrated POS and software into large enterprise accounts. Seen alongside PrognoPay in healthcare, it reinforces the importance of execution in complex, embedded environments at the same time integration and margin risks remain elevated.

Yet beneath the surface, investors should be aware that integration and execution risk around Worldpay could...

Global Payments' narrative projects $13.9 billion revenue and $2.3 billion earnings by 2029. This requires 16.2% yearly revenue growth and a $1.7 billion earnings increase from $630.2 million today.

Uncover how Global Payments' forecasts yield a $94.92 fair value, a 40% upside to its current price.

Exploring Other Perspectives

While PrognoPay hints at opportunity in embedded payments, some of the lowest ranked analysts were expecting only about US$14.1 billion of revenue and US$1.4 billion of earnings by 2029, so you should recognize how sharply opinions differ before deciding how this new healthcare partnership might reshape the risk of heavy dependence on large scale acquisitions.

Explore 8 other fair value estimates on Global Payments - why the stock might be worth over 3x more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Global Payments research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Global Payments research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Global Payments' overall financial health at a glance.

Curious About Other Options?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Find 47 companies with promising cash flow potential yet trading below their fair value.
• Rare earth metals are the new gold rush. Find out which 32 stocks are leading the charge.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.